Pfizer Inc. (PFE)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 160.59B |
| Enterprise value | 222.17B |
| Trailing P/E | N/A |
| Forward P/E | 10.12 |
| PEG ratio (5-yr expected) | 0.21 |
| Price/sales (ttm) | 2.90 |
| Price/book (mrq) | 1.83 |
| Enterprise value/revenue | 4.03 |
| Enterprise value/EBITDA | 40.51 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.62 |
| 52-week change 3 | -14.46% |
| S&P500 52-week change 3 | 32.30% |
| 52-week high 3 | 33.92 |
| 52-week low 3 | 25.20 |
| 50-day moving average 3 | 29.24 |
| 200-day moving average 3 | 28.17 |
Share statistics
| Avg vol (3-month) 3 | 31.45M |
| Avg vol (10-day) 3 | 29.83M |
| Shares outstanding 5 | 5.67B |
| Implied shares outstanding 6 | 5.67B |
| Float 8 | 5.66B |
| % held by insiders 1 | 0.05% |
| % held by institutions 1 | 67.48% |
| Shares short (13 Sept 2024) 4 | 74.84M |
| Short ratio (13 Sept 2024) 4 | 2.73 |
| Short % of float (13 Sept 2024) 4 | 1.32% |
| Short % of shares outstanding (13 Sept 2024) 4 | 1.32% |
| Shares short (prior month 15 Aug 2024) 4 | 61.73M |
Dividends & splits
| Forward annual dividend rate 4 | 1.68 |
| Forward annual dividend yield 4 | 5.93% |
| Trailing annual dividend rate 3 | 1.66 |
| Trailing annual dividend yield 3 | 5.80% |
| 5-year average dividend yield 4 | 4.20 |
| Payout ratio 4 | 443.24% |
| Dividend date 3 | 03 Sept 2024 |
| Ex-dividend date 4 | 26 July 2024 |
| Last split factor 2 | 1054:1000 |
| Last split date 3 | 17 Nov 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 30 June 2024 |
Profitability
| Profit margin | -4.70% |
| Operating margin (ttm) | 22.40% |
Management effectiveness
| Return on assets (ttm) | 0.94% |
| Return on equity (ttm) | -2.74% |
Income statement
| Revenue (ttm) | 55.17B |
| Revenue per share (ttm) | 9.76 |
| Quarterly revenue growth (yoy) | 2.10% |
| Gross profit (ttm) | N/A |
| EBITDA | 9.96B |
| Net income avi to common (ttm) | -2.59B |
| Diluted EPS (ttm) | -0.46 |
| Quarterly earnings growth (yoy) | -98.20% |
Balance sheet
| Total cash (mrq) | 7.1B |
| Total cash per share (mrq) | 1.25 |
| Total debt (mrq) | 69.86B |
| Total debt/equity (mrq) | 79.41% |
| Current ratio (mrq) | 0.86 |
| Book value per share (mrq) | 15.48 |
Cash flow statement
| Operating cash flow (ttm) | 8.01B |
| Levered free cash flow (ttm) | 3.44B |
© 2024 Yahoo. All rights reserved.